Molina Q3 GAAP EPS $5.65, adjusted $6.01; reaffirms FY guidance

MOLINA HEALTHCARE, INC.

2024-Q3 EPS reported $15.97 revenue$30,151,000,000

Q3 premium revenue $9.694B, up 17.6% YoY from $8.24B.
GAAP net income $326M ($5.65 diluted) vs $245M ($4.21) a year ago.
Adjusted net income $347M ($6.01 diluted) vs $294M ($5.05).
Medical care ratio 89.2% vs 88.7% YoY; G&A ratio improved to 6.5% from 7.1%.
Full-year 2024 revenue and EPS guidance reaffirmed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.